Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Wright

Showing results (451-460 of 510) with videos related to

Pageof 51
Sort By:
Transfusion|January 12, 2013
An analysis of risk factors for human immunodeficiency virus infection among Chinese blood donorsJingxing Wang, Jing Liu, Yi Huang, et al.
Journal of Pain and Symptom Management|February 1, 2014
Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future developmentShirley H Bush, Salmaan Kanji, José L Pereira, et al.
American Journal of Obstetrics & Gynecology MFM|July 11, 2025
Randomized controlled trial of the impact of ursodeoxycholic acid on glycemia in gestational diabetes mellitus: the GUARDS trialCatalina de Paco Matallana, Jose E Blanco-Carnero, Ana Company Calabuig, et al.
Journal of the American Heart Association|December 11, 2025
Polygenic Risk Scores for Preeclampsia Prediction Beyond Gold-Standard Clinical Models in Multiethnic PopulationsMaddalena Ardissino, Kypros Nicolaides, Frances Conti-Ramsden, et al.
Journal of Hepatology|December 15, 2010
Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infectionMichael P Manns, Marc Bourlière, Yves Benhamou, et al.
Statistics in Biopharmaceutical Research|June 30, 2021
Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 PandemicR Daniel Meyer, Bohdana Ratitch, Marcel Wolbers, et al.
The Journal of Infectious Diseases|January 22, 2014
Dolutegravir in antiretroviral-experienced patients with raltegravir- and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 studyAntonella Castagna, Franco Maggiolo, Giovanni Penco, et al.
Transfusion|September 25, 2012
Motivation and social capital among prospective blood donors in three large blood centers in BrazilThelma T Gonçalez, Claudia Di Lorenzo Oliveira, Anna Barbara F Carneiro-Proietti, et al.
American Journal of Obstetrics and Gynecology|August 9, 2017
Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical historyLiona C Poon, David Wright, Daniel L Rolnik, et al.
Journal of Neuro-Oncology|August 9, 2019
Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II)John D Hainsworth, Kevin P Becker, Tarek Mekhail, et al.
Pageof 51

Showing results (451-460 of 510) with videos related to

Sort By:
Pageof 51
Transfusion|January 12, 2013
An analysis of risk factors for human immunodeficiency virus infection among Chinese blood donorsJingxing Wang, Jing Liu, Yi Huang, et al.
Journal of Pain and Symptom Management|February 1, 2014
Treating an established episode of delirium in palliative care: expert opinion and review of the current evidence base with recommendations for future developmentShirley H Bush, Salmaan Kanji, José L Pereira, et al.
American Journal of Obstetrics & Gynecology MFM|July 11, 2025
Randomized controlled trial of the impact of ursodeoxycholic acid on glycemia in gestational diabetes mellitus: the GUARDS trialCatalina de Paco Matallana, Jose E Blanco-Carnero, Ana Company Calabuig, et al.
Journal of the American Heart Association|December 11, 2025
Polygenic Risk Scores for Preeclampsia Prediction Beyond Gold-Standard Clinical Models in Multiethnic PopulationsMaddalena Ardissino, Kypros Nicolaides, Frances Conti-Ramsden, et al.
Journal of Hepatology|December 15, 2010
Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infectionMichael P Manns, Marc Bourlière, Yves Benhamou, et al.
Statistics in Biopharmaceutical Research|June 30, 2021
Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 PandemicR Daniel Meyer, Bohdana Ratitch, Marcel Wolbers, et al.
The Journal of Infectious Diseases|January 22, 2014
Dolutegravir in antiretroviral-experienced patients with raltegravir- and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 studyAntonella Castagna, Franco Maggiolo, Giovanni Penco, et al.
Transfusion|September 25, 2012
Motivation and social capital among prospective blood donors in three large blood centers in BrazilThelma T Gonçalez, Claudia Di Lorenzo Oliveira, Anna Barbara F Carneiro-Proietti, et al.
American Journal of Obstetrics and Gynecology|August 9, 2017
Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical historyLiona C Poon, David Wright, Daniel L Rolnik, et al.
Journal of Neuro-Oncology|August 9, 2019
Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II)John D Hainsworth, Kevin P Becker, Tarek Mekhail, et al.
Pageof 51